Published in Gene Therapy Weekly, March 15th, 1999
The A2M genes code for variants of the protein a2-macroglobulin (a2M). A2M is only the second gene found to be a risk factor for developing late-onset Alzheimer's disease (AD); late-onset accounts for the vast majority of Alzheimer's cases. One of the a2M variants is found in approximately 30 percent of the U.S. population, the other in 42 percent. Thus, these variants could play a significant role...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly